he's your man

A recent report from the BBC about this study by the US Women's Health Initiative, shows that the risks of estrogen apparently far outweigh any of it's benefits.

Major research suggests hormone replacement therapy may increase the risk of developing dementia. It was found that, when the findings for the two groups were combined, women on either form of HRT had a 76% greater risk of developing dementia, compared to women who were taking dummy pills. Stephen Rapp, professor of psychiatry and behavioural medicine and one of the lead authors on the study, told BBC News Online: "Our findings show quite clearly that HRT should not be used to protect against the risk of dementia. "And for some women, there is an increased risk of developing dementia with hormonal therapy." 'Disappointing' Professor Peter Bowen-Simpkins of the Royal College of Obstetricians and Gynaecologists, said: "These findings are low in terms of numbers, but they are directly contrary to what we previously thought. "It's disappointing for the people who thought HRT could delay or prevent dementia." In July 2002, women involved in WHI studies were told to stop taking combined HRT because the risks of developing breast cancer, strokes and cardiovascular disease outweighed the benefits. In February 2004, women in the oestrogen-only study were told to stop taking their drugs due to an increased risk of stroke, and no benefit for heart disease.

So... Q: Who is profiting from the over-prescription of estrogen drugs to aging women? A: This man, Richard L Carrion, managing director of Wyeth Pharmaceuticals, and also Chairman of the Board, President and Chief Executive Officer of the Corporation and the Bank at Popular, Inc. Wyeth developed and distributes Premarin and Prempro... the top selling Hormone Replacement Therapy drugs on the market. Premarin has apparently been on the market since the 1950s. Carrion is also a director on the executive board at Verizon Communications, and widely-considered one of Latin America's most influential power brokers in Washington.